Hematologic Malignancies and Bone

Rebecca Silbermann, G. David Roodman

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Hematologic malignancies can have multiple direct and indirect effects on bone including pathologic fractures, bone pain, and hypercalcemia. This chapter discusses the pathophysiology of skeletal lesions in hematologic malignancies, with a focus on the current understanding of their associated bone disease, and includes brief discussions of radiologic imaging of skeletal lesions, pharmacologic treatments, and other hematologic malignancies that affect the bone. Multiple myeloma (MM) has the highest incidence of bone involvement among malignant diseases and is the second most common hematologic malignancy, accounting for approximately 15% of all hematologic malignancies. Magnetic resonance imaging (MRI) is effective in identification of lytic lesions and is indicated for staging in patients with solitary plasmacytoma of the bone. Currently, bisphosphonates remain the standard of care for MM-related bone disease. Adult T-cell leukemia/lymphoma (ATLL), non-Hodgkin's lymphoma (NHL), and Hodgkin's disease (HD) are the other hematologic malignancies discussed in the chapter.

Original languageEnglish (US)
Title of host publicationPrimer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition
PublisherWiley Blackwell
Pages694-701
Number of pages8
ISBN (Electronic)9781118453926
ISBN (Print)9781118453889
DOIs
StatePublished - Jul 19 2013

Fingerprint

Hematologic Neoplasms
Bone
Bone and Bones
Bone Diseases
Multiple Myeloma
Adult T Cell Leukemia Lymphoma
Spontaneous Fractures
Plasmacytoma
Diphosphonates
Hypercalcemia
Standard of Care
T-cells
Hodgkin Disease
Non-Hodgkin's Lymphoma
Magnetic resonance imaging
Magnetic Resonance Imaging
Pain
Imaging techniques
Incidence

Keywords

  • Adult T-cell leukemia/lymphoma (ATLL)
  • Bisphosphonates
  • Bone
  • Hematologic malignancies
  • Magnetic resonance imaging (MRI)
  • Multiple myeloma (MM)
  • Non-Hodgkin's lymphoma (NHL)

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Silbermann, R., & Roodman, G. D. (2013). Hematologic Malignancies and Bone. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition (pp. 694-701). Wiley Blackwell. https://doi.org/10.1002/9781118453926.ch84

Hematologic Malignancies and Bone. / Silbermann, Rebecca; Roodman, G. David.

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition. Wiley Blackwell, 2013. p. 694-701.

Research output: Chapter in Book/Report/Conference proceedingChapter

Silbermann, R & Roodman, GD 2013, Hematologic Malignancies and Bone. in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition. Wiley Blackwell, pp. 694-701. https://doi.org/10.1002/9781118453926.ch84
Silbermann R, Roodman GD. Hematologic Malignancies and Bone. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition. Wiley Blackwell. 2013. p. 694-701 https://doi.org/10.1002/9781118453926.ch84
Silbermann, Rebecca ; Roodman, G. David. / Hematologic Malignancies and Bone. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition. Wiley Blackwell, 2013. pp. 694-701
@inbook{2aa29f3fd0a54d3d95a1ae5f85144da2,
title = "Hematologic Malignancies and Bone",
abstract = "Hematologic malignancies can have multiple direct and indirect effects on bone including pathologic fractures, bone pain, and hypercalcemia. This chapter discusses the pathophysiology of skeletal lesions in hematologic malignancies, with a focus on the current understanding of their associated bone disease, and includes brief discussions of radiologic imaging of skeletal lesions, pharmacologic treatments, and other hematologic malignancies that affect the bone. Multiple myeloma (MM) has the highest incidence of bone involvement among malignant diseases and is the second most common hematologic malignancy, accounting for approximately 15{\%} of all hematologic malignancies. Magnetic resonance imaging (MRI) is effective in identification of lytic lesions and is indicated for staging in patients with solitary plasmacytoma of the bone. Currently, bisphosphonates remain the standard of care for MM-related bone disease. Adult T-cell leukemia/lymphoma (ATLL), non-Hodgkin's lymphoma (NHL), and Hodgkin's disease (HD) are the other hematologic malignancies discussed in the chapter.",
keywords = "Adult T-cell leukemia/lymphoma (ATLL), Bisphosphonates, Bone, Hematologic malignancies, Magnetic resonance imaging (MRI), Multiple myeloma (MM), Non-Hodgkin's lymphoma (NHL)",
author = "Rebecca Silbermann and Roodman, {G. David}",
year = "2013",
month = "7",
day = "19",
doi = "10.1002/9781118453926.ch84",
language = "English (US)",
isbn = "9781118453889",
pages = "694--701",
booktitle = "Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition",
publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - Hematologic Malignancies and Bone

AU - Silbermann, Rebecca

AU - Roodman, G. David

PY - 2013/7/19

Y1 - 2013/7/19

N2 - Hematologic malignancies can have multiple direct and indirect effects on bone including pathologic fractures, bone pain, and hypercalcemia. This chapter discusses the pathophysiology of skeletal lesions in hematologic malignancies, with a focus on the current understanding of their associated bone disease, and includes brief discussions of radiologic imaging of skeletal lesions, pharmacologic treatments, and other hematologic malignancies that affect the bone. Multiple myeloma (MM) has the highest incidence of bone involvement among malignant diseases and is the second most common hematologic malignancy, accounting for approximately 15% of all hematologic malignancies. Magnetic resonance imaging (MRI) is effective in identification of lytic lesions and is indicated for staging in patients with solitary plasmacytoma of the bone. Currently, bisphosphonates remain the standard of care for MM-related bone disease. Adult T-cell leukemia/lymphoma (ATLL), non-Hodgkin's lymphoma (NHL), and Hodgkin's disease (HD) are the other hematologic malignancies discussed in the chapter.

AB - Hematologic malignancies can have multiple direct and indirect effects on bone including pathologic fractures, bone pain, and hypercalcemia. This chapter discusses the pathophysiology of skeletal lesions in hematologic malignancies, with a focus on the current understanding of their associated bone disease, and includes brief discussions of radiologic imaging of skeletal lesions, pharmacologic treatments, and other hematologic malignancies that affect the bone. Multiple myeloma (MM) has the highest incidence of bone involvement among malignant diseases and is the second most common hematologic malignancy, accounting for approximately 15% of all hematologic malignancies. Magnetic resonance imaging (MRI) is effective in identification of lytic lesions and is indicated for staging in patients with solitary plasmacytoma of the bone. Currently, bisphosphonates remain the standard of care for MM-related bone disease. Adult T-cell leukemia/lymphoma (ATLL), non-Hodgkin's lymphoma (NHL), and Hodgkin's disease (HD) are the other hematologic malignancies discussed in the chapter.

KW - Adult T-cell leukemia/lymphoma (ATLL)

KW - Bisphosphonates

KW - Bone

KW - Hematologic malignancies

KW - Magnetic resonance imaging (MRI)

KW - Multiple myeloma (MM)

KW - Non-Hodgkin's lymphoma (NHL)

UR - http://www.scopus.com/inward/record.url?scp=84952777243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952777243&partnerID=8YFLogxK

U2 - 10.1002/9781118453926.ch84

DO - 10.1002/9781118453926.ch84

M3 - Chapter

SN - 9781118453889

SP - 694

EP - 701

BT - Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition

PB - Wiley Blackwell

ER -